In vitro vascularization of tissue engineered constructs by non-viral delivery of pro-angiogenic genes-Reference-Cited by-同舟云学术

In vitro vascularization of tissue engineered constructs by non-viral delivery of pro-angiogenic genes

Published:2021 Issue:6 Volume:9 Page:2067-2081
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Moreira Helena R.¹²³⁴⁵^ORCID,Raftery Rosanne M.⁶⁷⁸⁹¹⁰,da Silva Lucília P.¹²³⁴⁵,Cerqueira Mariana T.¹²³⁴⁵,Reis Rui L.¹²³⁴⁵,Marques Alexandra P.¹²³⁴⁵,O'Brien Fergal J.⁶⁷⁸⁹¹⁰

Affiliation:

1. 3B's Research Group

2. I3Bs – Research Institute on Biomaterials

3. Biodegradables and Biomimetics

4. Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine

5. University of Minho

6. Tissue Engineering Research Group

7. Dept. of Anatomy & Regenerative Medicine

8. Royal College of Surgeons in Ireland (RCSI)

9. Dublin

10. Ireland

Abstract

The angiogenic capacity of fibroblasts is maximized through the deliver of plasmids and release of angiogenic proteins. Consequentially, endothelial cells proliferate and organize, demonstrating the potential of the system where vascularization is required.

Funder

Horizon 2020 Framework Programme

Division of Human Resource Management

Health Research Board

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D0BM01560A

Reference62 articles.

1. G. M. Mitchell and W. A.Morrison , in Vascularization for Tissue Engineering and Regenerative Medicine , 2017